Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Cash Flow
Ranbaxy Laboratories Ltd.- (Amalgamation)
BSE Code 500359
ISIN Demat INE015A01028
Book Value (Rs) 1.53
NSE Code NA
Dividend Yield % 0.00
Market Cap(Rs Mn) 366028.04
TTM PE(x) 0.00
TTM EPS(Rs) -3.19
Face Value (Rs) 5  
Type:
(Rs. in Million)
ParticularsMar2014Dec2012Dec2011Dec2010Dec2009
Profit Before Tax-7417.5812448.94-26864.8221001.0110097.62
Adjustment5193.70-527.4616000.25-2413.55-9563.20
Changes In working Capital-29365.307029.4719450.112987.26270.64
Cash Flow after changes in Working Capital-31589.1818950.958585.5421574.72805.06
Cash Flow from Operating Activities-35623.9715821.006388.0515385.95-1621.25
Cash Flow from Investing Activities18319.67-18203.1816687.10-21707.54651.59
Cash Flow from Financing Activities10161.622369.24-12176.677908.20-5222.69
Net Cash Inflow / Outflow-7142.68-12.9410898.481586.61-6192.35
Opening Cash & Cash Equivalents18307.0618829.566812.105476.2411782.77
Cash & Cash Equivalent on Amalgamation / Take over / Merger00000
Cash & Cash Equivalent of Subsidiaries under liquidations00000
Translation adjustment on reserves / op cash balalces frgn subsidiaries00000
Effect of Foreign Exchange Fluctuations1261.69-509.561118.98-250.75-114.18
Closing Cash & Cash Equivalent12426.0718307.0618829.566812.105476.24